Skip to content

Prospective cohort study of Lanmaoa asiatica poisoning

Prospective cohort study of Lanmaoa asiatica poisoning

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082724
Enrollment
Unknown
Registered
2024-04-07
Start date
2023-09-08
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mushroom poisoning

Interventions

Lanmaoa asiatica poisoning group:NA

Sponsors

Affiliated Hospital of Yunnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Clear case history of consumption of Lanmaoa asiatica (picture identification); 2) Cases of Lanmaoa asiatica poisoning clearly diagnosed according to the "Consensus of Clinical Experts in the Diagnosis and Treatment of Mushroom Poisoning in China (2019)" ; 3) All cases were newly diagnosed in our hospital and other centers after poisoning; 4) Be willing to accept metabolomics analysis sample sampling and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with terminal organ failure; 2) Patients with a history of mental and neurological diseases.

Design outcomes

Primary

MeasureTime frame
Using " Wild Mushroom Poisoning Neuropsychiatric Symptoms Evaluation Scale " to evaluate the score;

Secondary

MeasureTime frame
all-cause mortality;

Countries

China

Contacts

Public ContactZheng Fenshuang

Affiliated Hospital of Yunnan University

503002938@qq.com+86 138 8858 8958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026